Organometallic Compounds
Medchemexpress LLC 1,2:3,5-di-O-isopropylidene-α-D-xylofuranose | 20881-04-3 | MFCD00063224 | 98.9% | 230.26 g/mol | C11H18O5 | 5 G
1,2:3,5-Di-O-isopropylidene-α-D-xylofuranose is an isopropylidene-protected derivative of α-D-xylofuranose supplied as a white to off-white solid. It is used as a protected sugar intermediate and building block in organic synthesis and carbohydrate chemistry, suitable for laboratory research and small-scale synthesis.
- Protected sugar intermediate for synthetic chemistry.
- High purity (approx. 98.9%) suitable for research applications.
- White to off-white solid for convenient handling and storage.
- Compatible with common carbohydrate modification and derivatization reactions.
- Available in typical laboratory pack sizes for small-scale use.
Medchemexpress LLC Mangafodipir (trisodium) | 140678-14-4 | 99.7% | 1 ML
Mangafodipir trisodium (MnDPDP) is a hepatocellular-specific contrast agent. It functions as an effective inhibitor of chemotherapy-induced peripheral neuropathy (CIPN) and other conditions caused by cellular oxidative stress. This agent demonstrates no negative interference with the tumoricidal activity of chemotherapy.
- Hepatocellular-specific contrast agent
- Inhibits chemotherapy-induced peripheral neuropathy (CIPN)
- Inhibits conditions caused by cellular oxidative stress
- Shows no negative interference with chemotherapy's tumoricidal activity
- Inhibits the effect of HGrC cell viability caused by H2O2
- Attenuates apoptosis caused by cisplatin in HGrC cells
- Shows protective effects against ovarian damage caused by cisplatin and paclitaxel in mice
Medchemexpress LLC Mangafodipir trisodium | 140678-14-4 | 99.7% | 100 MG
Mangafodipir trisodium (MnDPDP) is a hepatocellular-specific contrast agent and an efficacious inhibitor of chemotherapy-induced peripheral neuropathy (CIPN) and other conditions caused by cellular oxidative stress. It does not negatively interfere with the tumoricidal activity of chemotherapy.
- Inhibits effect of HGrC cell viability caused by H2O2
- Attenuates apoptosis caused by cisplatin in HGrC cells
- Shows protective effects against ovarian damage caused by cisplatin and paclitaxel in mice
Medchemexpress LLC N-Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine | 181951-92-8 | MFCD07781259 | >98.0% | 517.57 g/mol | C30H31NO7 | 1 G
N-Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine is an Fmoc-protected phenylalanine derivative used as a protected amino acid building block for peptide synthesis and chemical research. It features a tert-butoxycarbonyl-protected methoxy substituent at the 4-position of the aromatic ring and is supplied as a solid with formula C30H31NO7 and molecular weight 517.57 g/mol. Typical purity is ≥98.0% and recommended storage is powder: -20°C (up to 3 years) or 4°C (up to 2 years); in solvent: -80°C (up to 6 months) or -20°C (up to 1 month).
- Fmoc-protected amino acid suitable for solid-phase peptide synthesis.
- Boc-protected methoxy group at the 4-position of the aromatic ring.
- Chemical formula C30H31NO7 and molecular weight 517.57 g/mol.
- Purity ≥98.0% by 1H NMR.
- Supplied as a solid; follow recommended powder and solvent storage conditions.
- Intended for research use only.
Medchemexpress LLC S -2- 2- tert-Buto 250mg
(S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid (Boc-his(trt)-aib-ohol) is a drug intermediate for synthesis of various active compounds
Medchemexpress LLC Chloro-PEG5-chloride 25mg
Chloro-PEG5-chloride is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]